The neuroleptic butyrophenone drug spiroperidol (8-[4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro [4,5]decan-4-one) and related compounds are valuable tools for mapping the dopamine receptors in the brain. During the development of the radiochemical synthesis of these compounds with very short-lived isotopes suitable for positron emission tomography studies, positive electron impact mass spectrometric information was obtained. Ion series are present in the spectra of all 12 compounds studied, which unambiguously allow recognition of type and site of substitution on the spiro system.
Electron impact mass spectrometry of substituted 1,3,8-triazaspiro[4,5]decan-4-ones / B. Danieli, F.M. Rubino, L. Zecca. - In: BIOMEDICAL & ENVIRONMENTAL MASS SPECTROMETRY. - ISSN 0887-6134. - 18:11(1989 Nov), pp. 1000-1004.
Electron impact mass spectrometry of substituted 1,3,8-triazaspiro[4,5]decan-4-ones
B. DanieliPrimo
;F.M. RubinoSecondo
;
1989
Abstract
The neuroleptic butyrophenone drug spiroperidol (8-[4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro [4,5]decan-4-one) and related compounds are valuable tools for mapping the dopamine receptors in the brain. During the development of the radiochemical synthesis of these compounds with very short-lived isotopes suitable for positron emission tomography studies, positive electron impact mass spectrometric information was obtained. Ion series are present in the spectra of all 12 compounds studied, which unambiguously allow recognition of type and site of substitution on the spiro system.File | Dimensione | Formato | |
---|---|---|---|
04_1989 BEMS spiperones EI.pdf
accesso riservato
Descrizione: fotocopia pdf del reprint
Tipologia:
Publisher's version/PDF
Dimensione
300.21 kB
Formato
Adobe PDF
|
300.21 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.